Skip to main content
. 2019 Aug 28;4(4):e001613. doi: 10.1136/bmjgh-2019-001613

Figure 3.

Figure 3

Neutralising antibody titers for A/California/04/2009 H1N1 influenza, respiratory syncytial virus (RSV) and poliovirus (PV) types 1, 2 and 3 in stool samples collected 45 days’ postchallenge with monovalent oral polio vaccine type 1 in adults previously vaccinated with four doses of IPV in early childhood (N=12).